Purchases and Sales Made in Q2 2025 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q2 2025. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2025
Q2 2025
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
7KNew |
$6.02K - $8.82K
|
7K
$11K
|
|
Aug 14, 2025
Q2 2025
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
2.82K+ 1283.64% |
$2.43K - $3.56K
|
3.04K
$4.78K
|
|
Aug 04, 2025
Q2 2025
|
Spire Wealth Management
|
BUY
|
- |
500New |
$430 - $630
|
500
$785
|
|
Aug 14, 2025
Q2 2025
|
Raymond James Financial Inc
St. Petersburg, FL |
BUY
|
- |
57New |
$49 - $71.8
|
57
$89.5
|
|
Aug 12, 2025
Q2 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 13, 2025
Q2 2025
|
Neuberger Berman Group LLC
New York, NY |
SELL
|
- |
-3.01K- 21.51% |
$2.59K - $3.8K
|
11K
$17.3K
|
|
Aug 13, 2025
Q2 2025
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-4.6K- 68.21% |
$3.95K - $5.79K
|
2.14K
$3.36K
|
|
Aug 15, 2025
Q2 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-11.5K- 5.0% |
$9.92K - $14.5K
|
219K
$344K
|
|
Aug 13, 2025
Q2 2025
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-12.9K- 7.11% |
$11.1K - $16.3K
|
168K
$264K
|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-19.7K- 24.4% |
$16.9K - $24.8K
|
61.1K
$95.9K
|
|
Aug 14, 2025
Q2 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-56.8K- 8.49% |
$48.9K - $71.6K
|
612K
$961K
|
|
Aug 14, 2025
Q2 2025
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-369K- 20.69% |
$317K - $464K
|
1.41M
$2.22M
|